The Use of Complementary Alternative Medicine in HIV-infected Patients during COVID-19 Pandemic: Its Related Factors and Drug Interactions with Antiretroviral Therapy
National Cancer Institute. Complementary and Alternative Medicine (CAM). https://www.cancer.gov/about-cancer/treatment/cam (2021, assessed 2022 Feb 19).
Abou-Rizk J, Alameddine M, Naja F. Prevalence and characteristics of CAM use among people living with HIV and AIDS in Lebanon: Implications for patient care. Evid Based Complement Alternat Med. 2016;2016:1–11.
Elfahmi, Woerdenbag HJ, Kayser O. Jamu: Indonesian traditional herbal medicine towards rational phytopharmacological use. J Herbal Med. 2014;4(2):51–73.
World Health Organization. Global report on traditional and complementary medicine 2019. Available online http://apps.who.int/bookorders. 2019. Assessed on 2022 Feb 28.
Littlewood R, Vanable P. Complementary and alternative medicine use among HIV positive people: research synthesis and implications for HIV care. AIDS Care 2008;20(8):1002-18.
Littlewood R, Vanable PA. The relationship between CAM use and adherence to antiretroviral therapies among persons living with HIV. Heal Psychol. 2014; 33(7):660-7.
Bahall M. Prevalence, patterns, and perceived value of complementary and alternative medicine among HIV patients: a descriptive study. BMC Complement Altern Med. 2017;17(1):422.
James PB, Wardle J, Steel A, Adams J. Traditional, complementary and alternative medicine use in Sub-Saharan Africa: a systematic review. BMJ Global Health. 2018;3(5):e000895.
Braun LA, Forrester CA, Rawlins MD, et al. Complementary medicine use by people living with HIV in Australia – a national survey. Int J STD AIDS. 2016;27(1):33–8.
Endale Gurmu A, Teni FS, Tadesse WT. Pattern of traditional medicine utilization among HIV/AIDS patients on antiretroviral therapy at a university hospital in northwestern Ethiopia: A cross-sectional study. Evid Based Complement Alternat Med. 2017;2017:1–6.
Kelso-Chichetto NE, Okafor CN, Harman JS, Canidate SS, Cook CL, Cook RL. Complementary and alternative medicine use for HIV management in the State of Florida: medical monitoring project. J Altern Complement Med. 2016;22(11):880–6.
Laar AK, Lartey MY, Ankomah A, et al. Food elimination, food substitution, and nutrient supplementation among ARV-exposed HIV-positive persons in Southern Ghana. J Health Popul Nutr. 2018;37(1):26.
Kalichman SC, Cherry C, White D, et al. Use of dietary supplements among people living with HIV/AIDS is associated with vulnerability to medical misinformation on the internet. AIDS Res Ther. 2012;9(1):1.
Permatasari J, Hasina H, Pratama S. Studi penggunaan complementary and alternative medicine (CAM) pada ODHA di Yayasan Kanti Sehati Sejati kota Jambi. J Endurance. 2020;5(1):105.
Nugraha RV, Ridwansyah H, Ghozali M, Khairani AF, Atik N. Traditional herbal medicine candidates as complementary treatments for COVID-19: A review of their mechanisms, pros and cons. Evid Based Complement Alternat Med. 2020;2020:1–12.
Rokhmah D, Ali K, Putri SMD, Khoiron K. Increase in public interest concerning alternative medicine during the COVID-19 pandemic in Indonesia: A google trends study. F1000Res. 2021;9:1201.
Chang CC, Crane M, Zhou J, et al. HIV and co-infections. Immunol Rev. 2013;254(1):114–42.
Ssentongo P, Heilbrunn ES, Ssentongo AE, et al. Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis. Sci Rep. 2021;11(1):6283.
Brooks KM, George JM, Kumar P. Drug interactions in HIV treatment: complementary & alternative medicines and over-the-counter products. Expert Rev Clin Pharmacol. 2017;10(1):59–79.
Kementerian Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia nomor HK.01.07/MENKES/90/2019 tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana HIV 2019.
Liverpool HIV Interactions. https://www.hiv-druginteractions.org/ (assessed 2022 Feb 28].
Danwang C, Noubiap JJ, Robert A, Yombi JC. Outcomes of patients with HIV and COVID-19 co-infection: a systematic review and meta-analysis. AIDS Res Ther. 2022;19(1):3.
Dehghan M, Ghanbari A, Ghaedi Heidari F, Mangolian Shahrbabaki P, Zakeri MA. Use of complementary and alternative medicine in general population during COVID-19 outbreak: A survey in Iran. J Integr Med. 2022;20(1):45–51.
Paudyal V, Cadogan C, Fialová D, et al. Provision of clinical pharmacy services during the COVID-19 pandemic: Experiences of pharmacists from 16 European countries. Res Social Admin Pharm. 2021;17(8):1507–17.
Pullen MF, Skipper CP, Hullsiek KH, et al. Symptoms of COVID-19 outpatients in the United States. Open Forum Infect Dis. 2020;7(7):ofaa271.
Lorenc A, Robinson N. A Review of the use of complementary and alternative medicine and HIV: Issues for patient care. AIDS Patient Care STDs. 2013;27(9):503–10.
Bordes C, Leguelinel-Blache G, Lavigne J-P, et al. Interactions between antiretroviral therapy and complementary and alternative medicine: a narrative review. Clin Microbiol Infect. 2020;26(9):1161–70.
Song I, Borland J, Chen S, et al. Effect of food on the pharmacokinetics of the integrase inhibitor dolutegravir. Antimicrob Agents Chemother. 2012;56(3):1627–9.
Song I, Borland J, Arya N, Wynne B, Piscitelli S. Pharmacokinetics of dolutegravir when administered with mineral supplements in healthy adult subjects. J Clin Pharmacol. 2015;55(5):490–6.
Dolutegravir (Tivicay) Package Insert | DAIDS Regulatory Support Center (RSC) [Internet]. [cited 2022 Feb 28]. Available from: https://rsc.niaid.nih.gov/clinical-research-sites/dolutegravir-tivicay-package-insert
Duncan A, Mills J. An unusual case of HIV virologic failure during treatment with boosted atazanavir. AIDS. 2013;27(8):1361–2.
Naccarato M, Yoong D, Gough K. A potential drug–herbal interaction between Ginkgo biloba and efavirenz. J Int Assoc Physicians AIDS Care. 2012;11(2):98–100.
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 4.0 International License.